NYSE:IVC Invacare (IVC) Stock Price, News & Analysis → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free IVC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.35▼$0.7452-Week Range N/AVolume33,301 shsAverage Volume240,305 shsMarket Capitalization$20.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invacare alerts: Email Address Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Invacare Stock (NYSE:IVC)Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. IVC Stock News HeadlinesFebruary 27, 2024 | finance.yahoo.comNorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of ManagersFebruary 14, 2024 | sports.yahoo.comBuckeye Trail coasts past Newcomerstown for key IVC winApril 23, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”November 14, 2023 | finanznachrichten.deINVO Bioscience, Inc.: INVO Reports Record Third Quarter 2023 Financial ResultsOctober 14, 2023 | finance.yahoo.comIL&FS Investment Managers Limited (IVC.NS)August 22, 2023 | thestreet.comStocks Rally After CPI Comes Out in Line With ExpectationsJune 26, 2023 | finance.yahoo.comInvacare Holdings Corporation Names Kai Zhu Senior Vice President and Chief Financial OfficerMay 15, 2023 | finance.yahoo.comInvacare Reports Results for First Quarter 2023April 23, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”May 10, 2023 | marketwatch.comInvacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its TransformationApril 17, 2023 | finance.yahoo.comINVO Reports Fourth Quarter and Full Year 2022 Financial ResultsFebruary 1, 2023 | finance.yahoo.comInvacare files for bankruptcyFebruary 1, 2023 | finance.yahoo.comInvacare Files For Chapter 11, But Expects To Continue Focusing On Home-Care ProductsFebruary 1, 2023 | finance.yahoo.comInvacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International OperationsFebruary 1, 2023 | finance.yahoo.comInvacare files for bankruptcy, but expects to keep making and delivering home-care productsFebruary 1, 2023 | investorplace.comWhy Is Invacare (IVC) Stock Down 20% Today?December 27, 2022 | finance.yahoo.comInvacare draws more on term loan from hedge fund managerDecember 27, 2022 | finance.yahoo.comInvacare Corporation Announces Additional Draw of Term LoansNovember 23, 2022 | 247wallst.comAzurite Trims Invacare Stake after Inadvertently Passing 10% Ownership TriggerNovember 22, 2022 | finance.yahoo.comInvacare picks Geoff Purtill as permanent president, CEONovember 21, 2022 | finance.yahoo.comInvacare Appoints Geoff Purtill President and Chief Executive OfficerNovember 14, 2022 | finance.yahoo.comThe Consensus EPS Estimates For Invacare Corporation (NYSE:IVC) Just Fell DramaticallyNovember 10, 2022 | finance.yahoo.comInvacare Third Quarter 2022 Earnings: Misses ExpectationsNovember 7, 2022 | finance.yahoo.comInvacare Reports Results for Third Quarter 2022October 20, 2022 | businesswire.comInvacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results - Business WireOctober 20, 2022 | finance.yahoo.comInvacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial ResultsOctober 15, 2022 | globenewswire.comWheelchairs & Mobility Aids Market Research Report by Product, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - GlobeNewswireSee More Headlines Receive IVC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment Current SymbolNYSE:IVC CUSIP46120310 CIK742112 Webwww.invacare.com Phone(440) 329-6000Fax877-619-7996Employees3,000Year Founded1885Profitability EPS (Most Recent Fiscal Year)($2.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,560,000.00 Net Margins-9.99% Pretax Margin-9.38% Return on Equity-37.76% Return on Assets-7.18% Debt Debt-to-Equity Ratio4.82 Current Ratio1.32 Quick Ratio0.78 Sales & Book Value Annual Sales$872.46 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.77 Book Value$5.54 per share Price / BookN/AMiscellaneous Outstanding Shares37,760,000Free Float35,153,000Market Cap$20.01 million OptionableOptionable Beta0.38 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesGeoffrey P. PurtillPresident, Chief Executive Officer & DirectorKathleen Patricia LeneghanSenior VP, Chief Financial & Accounting OfficerAngie GoodwinSVP, Chief Technology & Information OfficerJoost BeltmanSenior VP & General Manager-North AmericaAnthony C. LaPlacaSecretary, Chief Administrative Officer & SVPKey CompetitorsNutribandNASDAQ:NTRBHeart Test LaboratoriesNASDAQ:HSCSPredictive OncologyNASDAQ:POAIReWalk RoboticsNASDAQ:LFWDMilestone ScientificNYSE:MLSSView All Competitors IVC Stock Analysis - Frequently Asked Questions How were Invacare's earnings last quarter? Invacare Co. (NYSE:IVC) released its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to analyst estimates of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%. During the same period in the previous year, the company earned ($0.10) earnings per share. What is Matthew E. Monaghan's approval rating as Invacare's CEO? 51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Invacare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO). This page (NYSE:IVC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invacare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
